Both CXCL13 and CCL25 are overexpressed in pSS and associated with B cell hyperactivity, the presence of autoantibodies and inflammatory mediators such as IL-21 and IFN-γ [10,26,27]. This evidence concerns the gene CXCL13 and peeling skin syndrome.